Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

A Zhang1, K Ohshima, K Sato

  • 1Department of Pathology, School of Medicine, Fukuoka University, Japan.

Pathology International
|January 13, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embodied Immunity: Place, Inequality, and Reproductive Outcomes in Two US Communities.

American journal of human biology : the official journal of the Human Biology Council·2026
Same author

Operational strategies among infectious disease clinical trial sites during pandemics: a scoping review.

Trials·2026
Same author

The value of fluorine-18 fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (<sup>18</sup>F-FDG PET/MRI) in characterising pleural effusion and detecting pleural metastasis for staging lung cancer.

Clinical radiology·2026
Same author

Autotrophic isopropanol production by Cupriavidus necator using industrial biogas and incinerator flue gases as carbon sources.

Journal of biotechnology·2026
Same author

Preoperative clinical scores compared with dual-energy computed tomography parameters in predicting complete resection of ovarian advanced high-grade serous carcinoma.

Clinical radiology·2025
Same author

Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium.

The American surgeon·2025

Clinical factors like age and International Prognostic Index (IPI) are more important than protein markers for diffuse large B-cell lymphoma (DLBCL) prognosis. High p53 and low bcl-6 expression correlate with shorter disease-free survival in DLBCL patients.

Area of Science:

  • Hematology
  • Oncology
  • Immunohistochemistry
  • Molecular Pathology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with variable clinical outcomes.
  • Identifying reliable prognostic markers is crucial for tailoring treatment strategies and improving patient survival in DLBCL.
  • Previous studies have explored various protein expressions, but their definitive prognostic value in DLBCL remains under investigation.

Purpose of the Study:

  • To evaluate the clinical significance and prognostic potential of specific protein markers in DLBCL.
  • To correlate protein expression profiles with clinical features and survival outcomes (overall survival and disease-free survival) in DLBCL patients.
  • To determine the relative importance of biological markers versus clinical factors in predicting DLBCL prognosis.

Related Experiment Videos

Main Methods:

  • Immunohistochemical analysis of tumor biopsies from 158 DLBCL patients for a panel of proteins including p53, p21/WAF1, bcl-2, cyclin-D1, bcl-6, mdr, CD5, CD30, EMA, Ki-67, and c-myc.
  • Selection of 76 patients (20-65 years) for detailed analysis of protein expression, clinical data, and survival.
  • Statistical analysis including survival analysis (OS, DFS) and multivariate analysis to identify significant prognostic factors.

Main Results:

  • Advanced stage, high lactate dehydrogenase, and high International Prognostic Index (IPI) were significant poor prognostic factors for OS and DFS.
  • High p53 expression and low bcl-6 expression were associated with shorter DFS.
  • Multivariate analysis identified age, IPI, and p53 as the most significant prognostic factors; p21/WAF1, mdr, and c-myc did not impact survival.

Conclusions:

  • Clinical factors, particularly age and IPI, are more critical than most biological markers in determining DLBCL prognosis.
  • p53 and bcl-6 protein expression show potential as useful prognostic indicators for DFS in DLBCL.
  • Certain histological variants (Cyclin-D1+ CD5+ or EMA+ CD30- DLBCL) may also have prognostic value, warranting further investigation.